Miss Amanda Raquel Medina Padilla, | |
813 Exeter Ct, Charlottesvle, VA 22901-1761 | |
(787) 955-7401 | |
Not Available |
Full Name | Miss Amanda Raquel Medina Padilla |
---|---|
Gender | Female |
Speciality | Pathology - Pediatric Pathology |
Location | 813 Exeter Ct, Charlottesvle, Virginia |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1952932980 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207ZP0213X | Pathology - Pediatric Pathology | 2204000372 (Virginia) | Primary |
Mailing Address | Practice Location Address |
---|---|
Miss Amanda Raquel Medina Padilla, Po Box 1140, Stanardsville, VA 22973-1140 Ph: (434) 939-9002 | Miss Amanda Raquel Medina Padilla, 813 Exeter Ct, Charlottesvle, VA 22901-1761 Ph: (787) 955-7401 |
News Archive
A pooled analysis of the SPIRIT II, III, IV and COMPARE trials presented today further reinforces the positive clinical performance of Abbott's market-leading XIENCE V Everolimus Eluting Coronary Stent System.
Oxford Gene Technology, The Molecular Genetics Company, has teamed up with clinical research experts in a new article available online, discussing the role of next generation sequencing (NGS) in cancer medicine.
Mersana Therapeutics, Inc., and the biopharmaceutical division of Merck KGaA, Darmstadt, Germany, which operates as EMD Serono in the United States and Canada, announced today an agreement to collaboratively develop next-generation antibody-drug conjugates (ADCs).
Today's headlines include reports about the scheduled House vote on repealing the health law as well as how stakeholders - whether it be certain governors or wall street investors - are responding to the Supreme Court's decision on the Medicaid expansion.
› Verified 6 days ago